Home/Filings/4/0001628280-19-015081
4//SEC Filing

Swirsky Douglas J 4

Accession 0001628280-19-015081

CIK 0000357097other

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 4:17 PM ET

Size

20.0 KB

Accession

0001628280-19-015081

Insider Transaction Report

Form 4
Period: 2019-12-13
Transactions
  • Disposition to Issuer

    Option to Purchase Common Stock

    2019-12-135340 total
    Exercise: $56.25Exp: 2023-03-04Common Stock (534 underlying)
  • Disposition to Issuer

    Options to purchase common stock

    2019-12-131,2000 total
    Exercise: $62.10Exp: 2024-06-20Common Stock (1,200 underlying)
  • Disposition to Issuer

    Option to Purchase Common Stock

    2019-12-136,0000 total
    Exercise: $16.55Exp: 2027-06-22Common Stock (6,000 underlying)
  • Disposition to Issuer

    Option to Purchase Common Stock

    2019-12-131,6000 total
    Exercise: $82.35Exp: 2023-07-19Common Stock (1,600 underlying)
  • Disposition to Issuer

    Option to Purchase Common Stock

    2019-12-132,4000 total
    Exercise: $81.60Exp: 2025-06-24Common Stock (2,400 underlying)
  • Disposition to Issuer

    Option to Purchase Common Stock

    2019-12-132,4000 total
    Exercise: $14.25Exp: 2026-06-22Common Stock (2,400 underlying)
  • Disposition to Issuer

    Option to Purchase Common Stock

    2019-12-136,0000 total
    Exercise: $2.36Exp: 2028-06-19Common Stock (6,000 underlying)
  • Disposition to Issuer

    Option to Purchase Common Stock

    2019-12-1312,0000 total
    Exercise: $1.94Exp: 2029-06-12Common Stock (12,000 underlying)
Footnotes (1)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated as of September 12, 2019 (the "Merger Agreement"), among Fibrocell Science, Inc. (the "Company"), Castle Creek Pharmaceutical Holdings, Inc. and Castle Creek Merger Corp., effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, these shares of Company common stock were converted into the right to receive a cash payment equal to the per share merger consideration of $3.00.

Issuer

Fibrocell Science, Inc.

CIK 0000357097

Entity typeother

Related Parties

1
  • filerCIK 0001375884

Filing Metadata

Form type
4
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:17 PM ET
Size
20.0 KB